Testicular Cancer, Plant-based Diets and Western Hospital Food: A Case Report

Author(s):  
Maximilian Storz

This is the case report of a young man who faced testicular cancer in his early 20s. His journey through hospital care was characterized by effective intervention-based medicine but lacked risk factor identification and management. Nutrition, a key component of cancer prevention and treatment, was never a subject of discussion. After receiving his diagnosis, the patient adopted a plant-based diet and never experienced a relapse. We therefore critically summarize and discuss the available studies associating particular foods with risk of testicular cancer. Finally, we cover the topic of hospital nutrition, based on insights from the patient’s history.

2019 ◽  
Vol 98 (7) ◽  
pp. 291-296

Introduction: Fournier’s gangrene is a rare but fast deteriorating and serious condition with high mortality. In most cases, it is characterized as necrotizing fasciitis of the perineum and external genitals. Amyand’s hernia is a rare condition where the appendix is contained in the sac of an inguinal hernia. Inflammatory alterations in the appendix account only for 0.1 % of the cases when Amyand’s hernia is verified. Fournier’s gangrene as a complication of a late diagnosis of appendicitis located in the inguinal canal is described in the literature as rare case reports. Case report: The case report of a 70-year-old patient with Fournier’s gangrene resulting from gangrenous appendicitis of Amyand’s hernia. Conclusion: Fournier’s gangrene as a complication of Amyand’s hernia is a rare condition. Only sporadic case reports thereof can be found in the literature. Because of the rarity of this pathology and the lack of randomized controlled studies, it is difficult to determine the optimal treatment according to the principles of evidence-based medicine. An appropriate approach for this condition appears to be the combination of guidelines developed in Amyand’s therapy according to Losanoff and Basson, along with the recommended “gold standard” therapy for Fournier’s gangrene. This means early and highly radical surgical debridement, adequate antibiotic therapy and intensive care.


Author(s):  
Francisco Sousa ◽  
Joana Vicente ◽  
Sara Azevedo ◽  
Ana Pinto ◽  
Cecília Sousa

Author(s):  
Sevtap Arslan ◽  
Yasin Sarıkaya ◽  
Musturay Karcaaltincaba ◽  
Ali Devrim Karaosmanoglu

Introduction: Aneurysm of the communicating vein between the left renal vein and left ascending lumbar vein is extremely rare with only anecdotal reported cases. Unless detected and recognized promptly, this rare condition may give rise to severe bleeding in patients undergoing retroperitoneal surgery. It may also closely mimic enlarged retroperitoneal lymph nodes, paragangliomas, adrenal masses, or renal artery aneurysms. Case report: In this case study, we reported the imaging findings of this rare entity which was falsely diagnosed as enlarged retroperitoneal lymph node in an outside medical center, reported as to be consistent with metastatic disease, in a patient with newly diagnosed testicular cancer. Conclusion: The aneurysm of the communicating vein should be considered in the differential diagnosis in patients with testicular cancer and other disease processes where lymph nodes are commonly affected.


Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 597
Author(s):  
Daniela Luvero ◽  
Salvatore Lopez ◽  
Giorgio Bogani ◽  
Francesco Raspagliesi ◽  
Roberto Angioli

Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market: bivalent, quadrivalent, and nonavalent. The nonavalent vaccine provides protection against almost 90% of HPV-related CC. Despite availability of primary and secondary prevention measures, CC persists as one of the most common cancers among women around the world. Although CC is a largely preventable disease, management of persistent or recurrent CC no longer amenable to control with surgery or radiation therapy has not improved significantly with the progress of modern chemotherapy and disseminated carcinoma of the cervix remains a discouraging clinical entity with a 1-year survival rate between 10% and 15%. Over the last few years, there has been increasing interest in immunotherapy as a strategy to fight tumors. This article focuses on recent discoveries about the HPV vaccine and immunotherapies in the prevention and treatment of CC, highlighting the future view.


IUBMB Life ◽  
2021 ◽  
Author(s):  
Sosmitha Girisa ◽  
Queen Saikia ◽  
Devivasha Bordoloi ◽  
Kishore Banik ◽  
Javadi Monisha ◽  
...  

2021 ◽  
pp. 101642
Author(s):  
Anahita Ansari Djafari ◽  
Katayoun Hasanzadeh ◽  
Homa Masrour ◽  
Mahsa Ahadi ◽  
Majid Dargahi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document